Labor Pain Clinical Trial
— OptimEpiOfficial title:
Intermittent Bolus Administration of Ropivacaine for Epidural Labor Analgesia : an Observational Study
NCT number | NCT02809742 |
Other study ID # | PMCurrieU2 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 2016 |
Est. completion date | July 4, 2019 |
Verified date | July 2019 |
Source | Pierre and Marie Curie University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Enhanced patient safety and satisfaction have contributed to growing use of epidural labor
analgesia. Epidural analgesia appears to be currently the most effective technique in
reducing pain during labor. However, reduction in total dose of local anesthetic and thus
motor blockade is crucial to improve the obstetric outcome. This technique has evolved from
intermittent boluses by anesthesiologists to the current standard labor epidural analgesic
regimens in many institutions in North America and Europe that consist of a local anesthetic
in combination with an opioid delivered via continuous epidural infusion (CEI) with or
without patient-controlled epidural analgesia (PCEA) boluses. Recently,a new mode of
administration has been used: regular bolus of low concentration local anesthetic +
intermittent bolus (PIEB). This technique would offer safe and superior quality labor
analgesia and greater maternal satisfaction by reducing total amount of the drug combination.
The primary outcome was to evaluate the analgesic efficacy of PIEB epidural drug delivery in
terms of visual analogue scale satisfaction (VAS) score in a large cohort of patients. The
secondary outcomes were to measure the degree of motor blockade, neonatal and obstetric
outcomes, total drug dose and incidence of pain that required top-up administration
(breakthrough pain)
Status | Completed |
Enrollment | 500 |
Est. completion date | July 4, 2019 |
Est. primary completion date | July 2016 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - healthy term primi or second gravid parturients - aged 18-30 years - singleton, live fetus - vertex presentation - active stage of labor with cervical dilation of 3-5 cm parturients Exclusion Criteria: - Hypertension - no vertex presentation - contraindications to neuraxial blockade |
Country | Name | City | State |
---|---|---|---|
France | CHU Nimes | Nimes | Gard |
Lead Sponsor | Collaborator |
---|---|
Pierre and Marie Curie University |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Verbal Analogue Satisfaction Score | VASS: 0-10: 0 = no satisfaction to 10 (total satisfaction) | 1 day | |
Secondary | maternal hypotension | Evaluation of adverse events over epidural infusion (mean arterial pressure< 65 mmHg) | 1 day | |
Secondary | Apgar score | The Apgar test is done by a doctor, midwife, or nurse. The health care provider examines the baby's: Breathing effort Heart rate Muscle tone Reflexes Skin color Each category is scored with 0, 1, or 2, depending on the observed condition. |
1 day | |
Secondary | Anesthetic rescue | Evaluation of the rescue performed by anesthesist over infusion | 1 day | |
Secondary | nausea | Number of maternal nausea event | 1 day | |
Secondary | fetal heart rate | Fetal heart sounds were monitored with a continuous Doppler machine | 1 day | |
Secondary | Motor blockade | Bromage score for maternal motor block | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03539562 -
Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
|
||
Withdrawn |
NCT04662450 -
Evaluation and Management of Parturients' Pain Intensity
|
N/A | |
Completed |
NCT02885350 -
Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour
|
Phase 4 | |
Completed |
NCT02550262 -
Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor
|
N/A | |
Completed |
NCT01598506 -
Intrathecal Hydromorphone for Labor Analgesia
|
Phase 2 | |
Withdrawn |
NCT01636999 -
Comparing Sedara to Butorphanol in Early Labor
|
N/A | |
Completed |
NCT00987441 -
Epidural Labor Analgesia and Infant Neurobehavior
|
N/A | |
Completed |
NCT00755092 -
Effect of Doula in Nulliparas and Multiparas
|
N/A | |
Terminated |
NCT00787176 -
The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes
|
N/A | |
Recruiting |
NCT06036797 -
Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia
|
Phase 2 | |
Completed |
NCT05512065 -
Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women
|
N/A | |
Completed |
NCT05327088 -
Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia
|
Phase 2 | |
Completed |
NCT03103100 -
Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation
|
Phase 3 | |
Recruiting |
NCT03623256 -
Comparison of Intrathecal Versus Epidural Fentanyl on Fetal Bradycardia in Labor Combined Spinal Epidural Analgesia
|
Phase 4 | |
Active, not recruiting |
NCT02271100 -
Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique
|
N/A | |
Completed |
NCT02926469 -
Virtual Reality Analgesia in Labor: The VRAIL Pilot Study
|
N/A | |
Completed |
NCT03712735 -
Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women
|
Phase 4 | |
Not yet recruiting |
NCT05565274 -
Outcome of Combined Tramadol and Paracetamol Versus Pentazocine as Labour Analgesia Among Parturients
|
N/A | |
Recruiting |
NCT02575677 -
Oxycodone in Treatment of Early Labour Pain Efficacy and Safety
|
||
Recruiting |
NCT01708668 -
The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia
|
N/A |